I agree that this site is using cookies. You can find further informations here.
X
Sciascia, Thomas
72  results:
Search for persons X
?
1

A Continuous Intestinal Absorption Model to Predict Drug En..:

Korzekwa, Ken ; Nagar, Swati ; Clark, David..
Molecular Pharmaceutics.  , 2024
Link: https://doi.org/10.1021/..
 
?
2

A population pharmacokinetic–pharmacodynamic model evaluati..:

Eudy‐Byrne, Rena ; Riggs, Matthew ; Hawi, Amale..
British Journal of Clinical Pharmacology.  89 (2023)  7 - p. 2088-2101 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Role of kappa‐opioid and mu‐opioid receptors in pruritus: P..:

Kim, Brian S. ; Inan, Saadet ; Ständer, Sonja...
Experimental Dermatology.  31 (2022)  12 - p. 1900-1907 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Modulation of the kappa and mu opioid axis for the treatmen..:

Elmariah, Sarina ; Chisolm, Sarah ; Sciascia, Thomas.
JAAD International.  7 (2022)  - p. 156-163 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and Safety of Oral Nalbuphine Extended Release in ..:

Weisshaar, Elke ; Sciascia, Thomas ; Stander, Sonja
SKIN The Journal of Cutaneous Medicine.  5 (2021)  1 - p. s29 , 2021
Link: https://doi.org/10.25251..
 
?
6

A Multicenter, Randomized, Double Double-Blind, Placebo Pla..:

Mathur, Vandana ; Sciascia, Thomas
SKIN The Journal of Cutaneous Medicine.  5 (2021)  1 - p. s28 , 2021
Link: https://doi.org/10.25251..
 
?
7

The Role of Kappa- and Mu-Opioid Receptors in Pruritus:

Kim, Brian ; Sciascia, Thomas ; Yosipovitch, Gil
SKIN The Journal of Cutaneous Medicine.  5 (2021)  1 - p. s31 , 2021
Link: https://doi.org/10.25251..
 
?
8

Modulation of the Mu and Kappa Opioid Axis for the Treatmen..:

Elmariah, Sarina ; Chisolm, Sarah ; Sciascia, Thomas.
SKIN The Journal of Cutaneous Medicine.  5 (2021)  1 - p. s30 , 2021
Link: https://doi.org/10.25251..
 
?
9

Pharmacokinetics of nalbuphine hydrochloride extended relea..:

Hawi, Amale ; Alcorn Jr, Harry ; Berg, Jolene...
BMC Nephrology.  16 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
10

Elevation of serum cardiac troponin I in a cross-sectional ..:

Friedman, Lisa S. ; Schadt, Kimberly A. ; Regner, Sean R....
International Journal of Cardiology.  167 (2013)  4 - p. 1622-1624 , 2013
Link: https://doi.org/10.1016/..
 
?
11

Use of an Adaptive Study Design in Single Ascending‐Dose Ph..:

Hawi, Amale ; Heald, Sarah ; Sciascia, Thomas
The Journal of Clinical Pharmacology.  52 (2012)  1 - p. 65-77 , 2012
Link: https://doi.org/10.1177/..
 
?
12

A0001 in Friedreich ataxia: Biochemical characterization an..:

Lynch, David R. ; Willi, Steven M. ; Wilson, Robert B....
Movement Disorders.  27 (2012)  8 - p. 1026-1033 , 2012
Link: https://doi.org/10.1002/..
 
?
13

43271 Patient-Reported Outcomes From the Randomized Phase 2..:

Ständer, Sonja ; Weisshaar, Elke ; Parish, Jennifer L....
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB73 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Oral Nalbuphine Extended-Release Is Effective in Severe Pru..:

Ständer, Sonja ; Weisshaar, Elke ; Parish, Jennifer L...
SKIN The Journal of Cutaneous Medicine.  6 (2022)  6 - p. s103 , 2022
Link: https://doi.org/10.25251..
 
?
15

25853 Efficacy and safety of oral nalbuphine extended relea..:

Weisshaar, Elke ; Szepietowski, Jacek C. ; Sciascia, Thomas R...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB72 , 2021
Link: https://doi.org/10.1016/..
 
1-15